Zoetis unveils $500 million buyback plan

Zoetis unveiled a new $500 million share-buyback program, a day after saying it would buy Abbott Laboratories’s animal-health business, and a week after activist investor William Ackman disclosed it took a $2 billion stock in Zoetis.